Matarin Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $423K | Sell |
32,202
-27,932
| -46% | -$367K | 0.1% | 168 |
|
|
2020
Q3 | $581K | Buy |
60,134
+28,386
| +89% | +$274K | 0.12% | 171 |
|
|
2020
Q2 | $363K | Buy |
+31,748
| New | +$363K | 0.07% | 180 |
|
|
2017
Q4 | – | Sell |
-38,075
| Closed | -$682K | – | 319 |
|
|
2017
Q3 | $682K | Hold |
38,075
| – | – | 0.06% | 221 |
|
|
2017
Q2 | $621K | Sell |
38,075
-25,002
| -40% | -$408K | 0.06% | 207 |
|
|
2017
Q1 | $883K | Buy |
+63,077
| New | +$883K | 0.09% | 197 |
|